We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Simple One-Hour Saliva Test Detects Common Cancers

By LabMedica International staff writers
Posted on 09 Mar 2026

Early detection is critical for improving cancer outcomes, yet many diagnostic tests rely on invasive procedures such as blood draws or biopsies. More...

Researchers are exploring simpler approaches that could enable rapid screening using readily collected samples, such as saliva. Scientists have developed a new saliva-based test that detects a protein biomarker associated with several cancer types within approximately one hour.

Researchers at Queensland University of Technology (QUT; Brisbane, Australi) have developed a portable diagnostic method to detect the protein biomarker S100P, which has been linked to oral, colon, pancreatic, prostate, and several other cancers. The test uses a paper-based sensor coated with gold and silver nanoparticles. These particles enable a detection technique known as surface-enhanced Raman spectroscopy (SERS), which identifies molecules based on how they scatter laser light.

The researchers created a paper sensor that selectively captures the S100P biomarker from saliva samples. To prepare the sensor, antibodies were chemically attached to the nanoparticle-coated paper using a light-driven synthesis process with deep ultraviolet LEDs. Once the biomarker binds to the sensor, the system records the Raman spectrum of the sample, allowing detection of S100P without requiring complex laboratory processing. The team also developed a target-specific paper extraction chip that isolates the biomarker before analysis, improving detection accuracy. The resulting method, published in Talanta, provides a rapid and low-cost way to detect S100P using a saliva sample.

Because the test uses saliva rather than blood or tissue biopsies, it may offer a noninvasive screening approach that could potentially be used in point-of-care settings. The paper-based sensor also reduces manufacturing costs and avoids complex chemical processes typically used in biomarker detection. Researchers suggest that the technology could help identify cancers or precancerous changes earlier, allowing doctors to intervene sooner. Further studies will be required to validate the method before it can be implemented in clinical screening programs.

“This method could shorten diagnosis time to minutes instead of hours or days and uses low-cost and portable materials,” said Associate Professor Emad Kiriakous, PhD.

Related Links:
Queensland University of Technology


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Thyroid Test
Anti-Thyroid EIA Test
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.